BACKGROUND: Expiratory muscle weakness and impaired airway clearance are early signs of respiratory dysfunction in Duchenne muscular dystrophy (DMD), a degenerative muscle disorder in which muscle cells are damaged and replaced by fibrofatty tissue. Little is known about expiratory muscle pathology and its relationship to cough and airway clearance capacity; however, the level of muscle replacement by fat can be estimated using MRI and expressed as a fat fraction (FF). RESEARCH QUESTION: How does abdominal expiratory muscle fatty infiltration change over time in DMD and relate to clinical expiratory function? STUDY DESIGN AND METHODS: Individuals with DMD underwent longitudinal MRI of the abdomen to determine FF in the internal oblique, external oblique, and rectus abdominis expiratory muscles. FF data were used to estimate a model of expiratory muscle degeneration by using nonlinear mixed effects and a cumulative distribution function. FVC, maximal inspiratory and expiratory pressures, and peak cough flow were collected as clinical correlates to MRI. RESULTS: Forty individuals with DMD (aged 6-18 years at baseline) participated in up to five visits over 36 months. Modeling estimated the internal oblique progresses most quickly and reached 50% replacement by fat at a mean patient age of 13.0 years (external oblique, 14.0 years; rectus abdominis, 16.2 years). Corticosteroid-untreated individuals (n = 4) reached 50% muscle replacement by fat 3 to 4 years prior to treated individuals. Individuals with mild clinical dystrophic phenotypes (n = 3) reached 50% muscle replacement by fat 4 to 5 years later than corticosteroid-treated individuals. Internal and external oblique FFs near 50% were associated with maximal expiratory pressures < 60 cm H2O and peak cough flows < 270 L/min. INTERPRETATION: These data improve understanding of the early phase of respiratory compromise in DMD, which typically presents as airway clearance dysfunction prior to the onset of hypoventilation, and links expiratory muscle fatty infiltration to pulmonary function measures.
BACKGROUND: Expiratory muscle weakness and impaired airway clearance are early signs of respiratory dysfunction in Duchenne muscular dystrophy (DMD), a degenerative muscle disorder in which muscle cells are damaged and replaced by fibrofatty tissue. Little is known about expiratory muscle pathology and its relationship to cough and airway clearance capacity; however, the level of muscle replacement by fat can be estimated using MRI and expressed as a fat fraction (FF). RESEARCH QUESTION: How does abdominal expiratory muscle fatty infiltration change over time in DMD and relate to clinical expiratory function? STUDY DESIGN AND METHODS: Individuals with DMD underwent longitudinal MRI of the abdomen to determine FF in the internal oblique, external oblique, and rectus abdominis expiratory muscles. FF data were used to estimate a model of expiratory muscle degeneration by using nonlinear mixed effects and a cumulative distribution function. FVC, maximal inspiratory and expiratory pressures, and peak cough flow were collected as clinical correlates to MRI. RESULTS: Forty individuals with DMD (aged 6-18 years at baseline) participated in up to five visits over 36 months. Modeling estimated the internal oblique progresses most quickly and reached 50% replacement by fat at a mean patient age of 13.0 years (external oblique, 14.0 years; rectus abdominis, 16.2 years). Corticosteroid-untreated individuals (n = 4) reached 50% muscle replacement by fat 3 to 4 years prior to treated individuals. Individuals with mild clinical dystrophic phenotypes (n = 3) reached 50% muscle replacement by fat 4 to 5 years later than corticosteroid-treated individuals. Internal and external oblique FFs near 50% were associated with maximal expiratory pressures < 60 cm H2O and peak cough flows < 270 L/min. INTERPRETATION: These data improve understanding of the early phase of respiratory compromise in DMD, which typically presents as airway clearance dysfunction prior to the onset of hypoventilation, and links expiratory muscle fatty infiltration to pulmonary function measures.
Authors: Alison M Barnard; Donovan J Lott; Abhinandan Batra; William T Triplett; Sean C Forbes; Samuel L Riehl; Rebecca J Willcocks; Barbara K Smith; Krista Vandenborne; Glenn A Walter Journal: J Neurol Date: 2019-07-26 Impact factor: 4.849
Authors: Michelle Chatwin; Michel Toussaint; Miguel R Gonçalves; Nicole Sheers; Uwe Mellies; Jesus Gonzales-Bermejo; Jesus Sancho; Brigitte Fauroux; Tiina Andersen; Brit Hov; Malin Nygren-Bonnier; Matthieu Lacombe; Kurt Pernet; Mike Kampelmacher; Christian Devaux; Kathy Kinnett; Daniel Sheehan; Fabrizio Rao; Marcello Villanova; David Berlowitz; Brenda M Morrow Journal: Respir Med Date: 2018-02-06 Impact factor: 3.415
Authors: Daniel W Sheehan; David J Birnkrant; Joshua O Benditt; Michelle Eagle; Jonathan D Finder; John Kissel; Richard M Kravitz; Hemant Sawnani; Richard Shell; Michael D Sussman; Lisa F Wolfe Journal: Pediatrics Date: 2018-10 Impact factor: 7.124
Authors: Philip H Quanjer; Sanja Stanojevic; Tim J Cole; Xaver Baur; Graham L Hall; Bruce H Culver; Paul L Enright; John L Hankinson; Mary S M Ip; Jinping Zheng; Janet Stocks Journal: Eur Respir J Date: 2012-06-27 Impact factor: 16.671
Authors: William D Rooney; Yosef A Berlow; William T Triplett; Sean C Forbes; Rebecca J Willcocks; Dah-Jyuu Wang; Ishu Arpan; Harneet Arora; Claudia Senesac; Donovan J Lott; Gihan Tennekoon; Richard Finkel; Barry S Russman; Erika L Finanger; Saptarshi Chakraborty; Elliott O'Brien; Brendan Moloney; Alison Barnard; H Lee Sweeney; Michael J Daniels; Glenn A Walter; Krista Vandenborne Journal: Neurology Date: 2020-03-17 Impact factor: 9.910